Replies to post #392 on MyMD Pharmaceuticals Inc (MYMD)

[Twice Worthy]

Currently in Phase ! ... Phase 2 commencing in July ... dosing trials with cohorts almost complete ... the FDA's Safety Committee monitoring the patients on the new drug has already noted that there were no toxicity issues with the drug thus far. Company evaluating which dose is the most effective.